Medtronic data breach exposes sensitive personal information

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Medtronic, Inc. disclosed a data breach in April 2026 that exposed the sensitive personal information of hundreds of thousands of individuals. The compromised data includes names, Social Security numbers, medical information, addresses, and dates of birth. Murphy Law Firm is investigating legal claims and evaluating a potential class action lawsuit on behalf of those affected.

powered bylight_fuzz_icon
44413680

*this image is generated using AI for illustrative purposes only.

Medtronic, Inc. disclosed that a data breach in April 2026 exposed the sensitive personal information of hundreds of thousands of individuals. The breach involved suspicious activity on its computer network, which forensic investigations confirmed was infiltrated by cybercriminals. The compromised data includes names, Social Security numbers, medical information, addresses, and dates of birth.

The investigation determined that cybercriminals gained access to files containing this sensitive information through an inadequately secured network. As a result, the exposed data may now be available on the dark web or used for identity theft and fraud.

Murphy Law Firm is investigating legal claims on behalf of affected individuals. The firm is evaluating options, including a potential class action lawsuit, to seek compensation for those impacted by the breach.

The following types of information were exposed in the incident:

Data Type
Names
Social Security numbers
Medical information
Addresses
Dates of birth

Individuals who received notice of the breach or believe their information was compromised are encouraged to join the investigation. Murphy Law Firm specializes in data breach class actions and consumer class actions.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What financial impact will this breach have on Medtronic's upcoming earnings and stock performance?

How will this incident influence future cybersecurity regulations for healthcare and medical device companies?

What long-term measures will Medtronic implement to prevent similar breaches and restore consumer trust?

like20
dislike

Needham reiterates Buy rating on Medtronic

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Needham analyst Mike Matson has reiterated a Buy rating for Medtronic, maintaining a price target of $101.

powered bylight_fuzz_icon
43237973

*this image is generated using AI for illustrative purposes only.

Needham analyst Mike Matson has reaffirmed a Buy rating for Medtronic, maintaining a price target of $101. The endorsement reflects continued confidence in the medical device company's stock performance.

Analyst Rating

The rating reiteration comes as Medtronic trades on the NYSE under the ticker symbol MDT. The $101 price target suggests potential upside from current levels.

Firm Analyst Rating Price Target
Needham Mike Matson Buy $101
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors could drive Medtronic's stock to reach the $101 price target?

How might recent regulatory changes impact Medtronic's product pipeline and revenue growth?

What are the potential risks to Medtronic's market position from emerging competitors?

like18
dislike